Sublingual Apomorphine
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application 61/186,445, filed Jun 12, 2009. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,044,475 | Sublingual Apomorphine In force · Medium confidence | Sunovion Pharmaceuticals Inc. | In force | Medium confidence | ||
| US 9,326,981 | Sublingual Apomorphine In force · High confidence | Sunovion Pharmaceuticals Inc. | In force | High confidence | ||
| US 10,420,763 | Sublingual Apomorphine In force · Medium confidence | Sunovion Pharmaceuticals Inc. | In force | Medium confidence | ||
| US 9,669,018 | Sublingual Apomorphine Lapsed Jun 6, 2025 on the fee record Medium confidence | Sunovion Pharmaceuticals Inc. | Lapsed Jun 6, 2025 on the fee record | Medium confidence | ||
| US 9,669,019 | Sublingual Apomorphine Lapsed Jun 6, 2025 on the fee record Medium confidence | Sunovion Pharmaceuticals Inc. | Lapsed Jun 6, 2025 on the fee record | Medium confidence | ||
| US 9,669,020 | Sublingual Apomorphine Lapsed Jun 6, 2025 on the fee record Medium confidence | Sunovion Pharmaceuticals Inc. | Lapsed Jun 6, 2025 on the fee record | Medium confidence | ||
| US 9,669,021 | Sublingual Apomorphine Lapsed Jun 6, 2025 on the fee record Medium confidence | Sunovion Pharmaceuticals Inc. | Lapsed Jun 6, 2025 on the fee record | Medium confidence | ||
| Application 14/962,806 | Sublingual Apomorphine Abandoned Abandoned Oct 29, 2018 | Sunovion Pharmaceuticals Inc. | Abandoned | Abandoned Oct 29, 2018 | ||
| Application 16/535,501 | Sublingual Apomorphine Abandoned Abandoned Jun 30, 2021 | Sunovion Pharmaceuticals Inc. | Abandoned | Abandoned Jun 30, 2021 | ||
| Application 17/186,439 | Sublingual Apomorphine Abandoned Abandoned Dec 1, 2023 | Sunovion Pharmaceuticals Inc. | Abandoned | Abandoned Dec 1, 2023 |
10 of 10 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Sunovion Pharmaceuticals Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.